Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

Summary

This study proposes to: 1. Characterize the impact of oral vancomycin on C. difficile loads after end of treatment compared to a placebo group. 2. Determine the effect of oral vancomycin on structural and functional microbiome changes after end of treatment compared to a placebo group. 3. Characterize the impact of oral vancomycin against a placebo group on the daily frequency of loose stools by the end of treatment.

Timeline

Start

2019-07-17

Primary completion

2021-06-01

Completion

2021-06-30

Drugs

Indications